|
US8759297B2
(en)
|
2006-08-18 |
2014-06-24 |
Armagen Technologies, Inc. |
Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
|
|
AU2008282496B2
(en)
|
2007-07-27 |
2013-04-04 |
Armagen Technologies, Inc. |
Methods and compositions for increasing alpha-iduronidase activity in the CNS
|
|
EP2485761B1
(en)
|
2009-10-09 |
2019-02-27 |
Armagen, Inc. |
Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
|
|
PL2701510T3
(pl)
|
2011-04-25 |
2017-07-31 |
Usher Iii Initiative Inc |
Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera
|
|
US9309250B2
(en)
|
2011-06-22 |
2016-04-12 |
Vertex Pharmaceuticals Incorporated |
Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
|
|
RS63930B1
(sr)
|
2011-10-28 |
2023-02-28 |
Prothena Biosciences Ltd |
Humanizovana antitela koja prepoznaju alfa-sinuklein
|
|
KR101998818B1
(ko)
|
2011-11-03 |
2019-07-10 |
한민규 |
무선 통신 장치의 장치 식별 정보를 이용한 컨텐츠 표시 방법, 컨텐츠 제공 방법, 상기 컨텐츠 표시 방법을 수행하는 사용자 단말 및 상기 컨텐츠 제공 방법을 수행하는 컨텐츠 제공 시스템
|
|
US20140323581A1
(en)
*
|
2011-12-05 |
2014-10-30 |
The Trustees Of Columbia University In The City Of New York |
Transcriptome wiring analysis in parkinson's disease and uses thereof
|
|
DK2807188T3
(da)
|
2012-01-27 |
2019-10-07 |
Prothena Biosciences Ltd |
Humaniserede antistoffer, der genkender alpha-synuclein
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
JP2015518872A
(ja)
*
|
2012-06-06 |
2015-07-06 |
フォンダッツィオーネ・テレソン |
アロステリックシャペロンおよびその使用
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
US9227976B2
(en)
|
2012-10-25 |
2016-01-05 |
Usher Iii Initiative, Inc. |
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
|
|
AU2013337354A1
(en)
|
2012-11-05 |
2015-05-21 |
Genzyme Corporation |
Compositions and methods for treating proteinopathies
|
|
SI2941432T1
(en)
|
2012-12-07 |
2018-07-31 |
Vertex Pharmaceuticals Incorporated |
2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
|
|
EP2970288A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US8957078B2
(en)
|
2013-03-15 |
2015-02-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
WO2014143240A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
|
EP3010532A4
(en)
*
|
2013-06-18 |
2017-06-14 |
University of North Carolina at Pembroke |
Materials for positive cathepsin b modulation and methods of use for treating mild cognitive impairment (mci), early dementia, a-synucleinopathy, traumatic brain injury, cardiomyopathy, eye disease and skin damage
|
|
US10513555B2
(en)
*
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
PT3052485T
(pt)
|
2013-10-04 |
2021-10-22 |
Infinity Pharmaceuticals Inc |
Compostos heterocíclicos e suas utilizações
|
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
PT3077397T
(pt)
|
2013-12-06 |
2020-01-22 |
Vertex Pharma |
Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo
|
|
WO2015121339A1
(en)
|
2014-02-14 |
2015-08-20 |
RUHR-UNIVERSITäT BOCHUM |
Biosensor for conformation and secondary structure analysis
|
|
MX382033B
(es)
|
2014-03-19 |
2025-03-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
|
|
CA2944402A1
(en)
|
2014-04-08 |
2015-10-15 |
Prothena Biosciences Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
|
MX373102B
(es)
|
2014-06-05 |
2020-04-17 |
Vertex Pharma |
Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de ataxia telangiectasia mutada y rad3 relacionado (atr) cinasa, preparación de tal compuesto y diferentes formas sólidas del mismo.
|
|
SG11201610500WA
(en)
|
2014-06-17 |
2017-01-27 |
Vertex Pharma |
Method for treating cancer using a combination of chk1 and atr inhibitors
|
|
CN105330579B
(zh)
*
|
2014-08-08 |
2019-08-30 |
杭州雷索药业有限公司 |
依泽替米贝及其衍生物在治疗或预防癫痫中的应用
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP4406616A3
(en)
|
2014-11-06 |
2024-11-06 |
Bial-R&D Investments, S.A. |
Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
|
|
US20170333435A1
(en)
|
2014-11-06 |
2017-11-23 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
US20180185368A1
(en)
|
2014-11-06 |
2018-07-05 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
WO2016077706A1
(en)
|
2014-11-13 |
2016-05-19 |
Washington University |
Treatment for wolfram syndrome and other endoplasmic reticulum stress disorders
|
|
CN107205976A
(zh)
*
|
2014-11-19 |
2017-09-26 |
拉什大学医学中心 |
用于治疗溶酶体病症的组合物和方法
|
|
TW201642855A
(zh)
*
|
2015-03-10 |
2016-12-16 |
健臻公司 |
用於治療蛋白質病變之方法
|
|
US10016514B2
(en)
|
2015-05-15 |
2018-07-10 |
New Hope Research Foundation |
Polynucleotides, vectors and methods for insertion and expression of transgenes
|
|
WO2016201266A1
(en)
|
2015-06-11 |
2016-12-15 |
Usher Iii Initiative, Inc. |
Methods of treating or preventing a proteopathy
|
|
TWI617573B
(zh)
*
|
2015-08-06 |
2018-03-11 |
中央研究院 |
用於酵素置換療法的改造酵素
|
|
WO2017040971A1
(en)
*
|
2015-09-03 |
2017-03-09 |
Biomarin Pharmaceutical Inc. |
Methods of using inhibitors of pikfyve for the treatment of lysosomal storage disorders and neurodegenerative diseases
|
|
WO2017048702A1
(en)
|
2015-09-14 |
2017-03-23 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
US20190018000A1
(en)
|
2016-01-12 |
2019-01-17 |
Cedars-Sinai Medical Center |
A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
|
|
CN105534977A
(zh)
*
|
2016-01-14 |
2016-05-04 |
山东大学 |
T型钙离子通道抑制剂nnc55-0396在制备抗神经退行性疾病药物中的应用
|
|
EP3411470A4
(en)
|
2016-02-01 |
2019-10-09 |
Emulate, Inc. |
SYSTEMS AND METHOD FOR BREEDING DARM CELLS IN MICROFLUIDIC DEVICES
|
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
|
KR20180124971A
(ko)
*
|
2016-03-25 |
2018-11-21 |
젠자임 코포레이션 |
단백질병증의 바이오마커 및 이의 용도
|
|
CA3020305A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics Inc. |
Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
EP3440081A4
(en)
*
|
2016-04-06 |
2019-09-18 |
Lysosomal Therapeutics Inc. |
PYRROLO [1,2-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER
|
|
AU2017246455B2
(en)
|
2016-04-06 |
2021-09-30 |
Bial - R&D Investments, S.A. |
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
KR102530515B1
(ko)
|
2016-05-05 |
2023-05-09 |
비알 - 알&디 인베스트먼츠, 에스.에이. |
치환된 이미다조[1,2-b]피리다진, 치환된 이미다조[1,5-b]피리다진, 관련 화합물, 및 의학적 장애의 치료에서의 그의 용도
|
|
WO2017192931A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP3318277A1
(en)
*
|
2016-11-04 |
2018-05-09 |
Institut du Cerveau et de la Moelle Epiniere-ICM |
Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
|
|
WO2018090054A1
(en)
*
|
2016-11-14 |
2018-05-17 |
Berg Llc |
Methods for treating parkinson's disease
|
|
ES2834484T3
(es)
|
2016-11-21 |
2021-06-17 |
Univ Ruhr Bochum |
Método para la preselección de fármacos para enfermedades de plegamiento incorrecto de proteínas
|
|
CN110325516A
(zh)
|
2016-12-29 |
2019-10-11 |
米尼奥尔克斯治疗有限公司 |
杂芳基化合物和它们的用途
|
|
US11913022B2
(en)
|
2017-01-25 |
2024-02-27 |
Cedars-Sinai Medical Center |
In vitro induction of mammary-like differentiation from human pluripotent stem cells
|
|
US11767513B2
(en)
|
2017-03-14 |
2023-09-26 |
Cedars-Sinai Medical Center |
Neuromuscular junction
|
|
WO2018176001A2
(en)
|
2017-03-24 |
2018-09-27 |
Cedars-Sinai Medical Center |
Methods and compositions for production of fallopian tube epithelium
|
|
EP3661961A4
(en)
*
|
2017-08-02 |
2021-04-14 |
Stressmarq Biosciences Inc. |
ANTIBODIES BINDING TO ACTIVE ALPHA-SYNUCLEIN
|
|
FI3678739T3
(fi)
*
|
2017-09-07 |
2024-05-21 |
Childrens Hospital Philadelphia |
Koostumuksia ja menetelmiä periytyvän kystatiini c -amyloidiangiopatian (hccaa) ja muiden poikkeaviin amyloidikertymiin liittyvien hermostoa rappeuttavien häiriöiden hoitoon
|
|
CR20200129A
(es)
|
2017-10-02 |
2020-08-22 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
|
|
AU2018346597B2
(en)
|
2017-10-06 |
2023-07-13 |
Forma Therapeutics, Inc. |
Inhibiting Ubiquitin Specific Peptidase 30
|
|
WO2019150192A1
(en)
*
|
2018-02-02 |
2019-08-08 |
Enzyvant Therapeutics Gmbh |
Methods for treating farber disease
|
|
EP4700387A2
(en)
|
2018-03-23 |
2026-02-25 |
Cedars-Sinai Medical Center |
Methods of use of islet cells
|
|
WO2019195800A1
(en)
|
2018-04-06 |
2019-10-10 |
Cedars-Sinai Medical Center |
Novel differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
|
|
WO2019195798A1
(en)
|
2018-04-06 |
2019-10-10 |
Cedars-Sinai Medical Center |
Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip
|
|
CN112203697A
(zh)
|
2018-04-13 |
2021-01-08 |
马萨诸塞大学 |
编码氨基己糖苷酶alpha和beta亚基的双顺反子AAV载体及其用途
|
|
EP3787613B1
(en)
*
|
2018-04-30 |
2026-03-11 |
Cedars-Sinai Medical Center |
Pkc activation for use in treating early onset sporadic parkinson's disease
|
|
JP7449242B2
(ja)
|
2018-05-17 |
2024-03-13 |
フォーマ セラピューティクス，インコーポレイテッド |
ユビキチン特異的ペプチダーゼ３０（ｕｓｐ３０）阻害剤として有用な縮合二環化合物
|
|
WO2019234243A1
(en)
*
|
2018-06-08 |
2019-12-12 |
Ac Immune Sa |
Novel compounds for diagnosis
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
US12448629B2
(en)
|
2018-10-05 |
2025-10-21 |
University Of Massachusetts |
rAAV vectors for the treatment of GM1 and GM2 gangliosidosis
|
|
JP7530889B2
(ja)
|
2018-10-05 |
2024-08-08 |
フォーマ セラピューティクス，インコーポレイテッド |
ユビキチン特異的プロテアーゼ３０（ｕｓｐ３０）阻害剤として作用する縮合ピロリン
|
|
SG11202105606XA
(en)
|
2018-12-05 |
2021-06-29 |
Univ Washington |
Methods of detecting, preventing, reversing, and treating neurological diseases
|
|
US20210403584A1
(en)
*
|
2019-01-08 |
2021-12-30 |
Armagen, Inc. |
Methods and compositions for increasing galactosidase beta-1 activity in the cns
|
|
CN114040762A
(zh)
|
2019-02-04 |
2022-02-11 |
建新公司 |
使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病
|
|
CN113645969A
(zh)
*
|
2019-02-04 |
2021-11-12 |
建新公司 |
用于治疗与溶酶体贮积症相关的症状和病症的方法
|
|
EP3920921A4
(en)
*
|
2019-02-07 |
2022-11-02 |
Alsatech, Inc. |
POLYVALENT EMOXYPIN DERIVATIVES
|
|
CA3132379A1
(en)
*
|
2019-03-22 |
2020-10-01 |
Rush University Medical Center |
Combination of nasal gene delivery and oral cinnamic acid, oleamide or gemfibrozil for lysosomal storage disorders
|
|
JP2022531177A
(ja)
*
|
2019-04-29 |
2022-07-06 |
トーマス・ジェファーソン・ユニバーシティ |
神経変性障害を治療するための方法
|
|
WO2020257736A1
(en)
|
2019-06-21 |
2020-12-24 |
The Broad Institute, Inc. |
Agents for reversing toxic proteinopathies
|
|
AU2020302992A1
(en)
*
|
2019-06-28 |
2022-02-03 |
The Trustees Of The University Of Pennsylvania |
Intranasal dantrolene administration for treatment of Alzheimer's Disease
|
|
JP7539382B2
(ja)
*
|
2019-07-29 |
2024-08-23 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN110579457B
(zh)
*
|
2019-09-20 |
2021-11-02 |
郑州大学第一附属医院 |
波形蛋白特异响应性荧光探针及其制备方法和应用
|
|
AU2021209954A1
(en)
*
|
2020-01-23 |
2022-09-01 |
Retispec Inc. |
Systems and methods for disease diagnosis
|
|
JP2023512366A
(ja)
|
2020-02-03 |
2023-03-27 |
ジェンザイム・コーポレーション |
リソソーム蓄積性疾患と関連する神経学的症状を処置するための方法
|
|
BR112022019864A2
(pt)
*
|
2020-03-31 |
2022-11-16 |
Nuo Beta Pharmaceutical Tech Shanghai Co Ltd |
Composto de oxofenilarsina deuterada e uso do mesmo
|
|
CN113720812A
(zh)
*
|
2020-05-26 |
2021-11-30 |
重庆福莱鲨生物技术有限公司 |
一种测定蛋白溶解度的方法
|
|
EP4178580B1
(en)
|
2020-07-09 |
2025-11-05 |
Usher III Initiative, Inc. |
Bf 844 for use in the treatment of cancer
|
|
AU2021311131B2
(en)
|
2020-07-24 |
2026-02-19 |
Genzyme Corporation |
Pharmaceutical compositions comprising venglustat
|
|
KR20230128462A
(ko)
|
2020-11-19 |
2023-09-05 |
제브라 덴마크 에이/에스 |
아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
|
|
US20240148722A1
(en)
*
|
2021-02-20 |
2024-05-09 |
Biohaven Therapeutics Ltd. |
Small molecules that bind to tdp-43 for the treatment of als and related disorders
|
|
CN113332267A
(zh)
*
|
2021-03-31 |
2021-09-03 |
中山大学孙逸仙纪念医院 |
苯丁酸钠在制备预防或治疗帕金森病的药物中的应用
|
|
WO2022255893A1
(en)
*
|
2021-06-02 |
2022-12-08 |
Qatar Foundation For Education, Science And Community Development |
Methods for diagnosing and differentiating synucleinopathies
|
|
WO2023042178A2
(en)
*
|
2021-09-20 |
2023-03-23 |
Aleta Neuroscience, Llc |
Combination therapy for neurodegenerative diseases
|
|
CN116392490A
(zh)
*
|
2021-12-27 |
2023-07-07 |
中国科学院广州生物医药与健康研究院 |
氟桂利嗪的用途以及控制细胞内线粒体数量的方法
|
|
CN119236096B
(zh)
*
|
2024-10-11 |
2026-03-06 |
苏州大学 |
Grp94蛋白作为递药靶点在帕金森病药物载体构建中的应用
|
|
CN120771139A
(zh)
*
|
2025-07-18 |
2025-10-14 |
昆明理工大学 |
维拉帕米在制备治疗Rett综合征药物中的应用
|